Skip to content

Xylazine Screening Test: Purpose, Procedure, and What Your Results Mean for Your Health and Safety

Published: August 9, 2026Updated: August 16, 2026

This confirmatory urine test detects 4-hydroxy xylazine, a metabolite of xylazine, to confirm exposure to this veterinary sedative drug.

Quick summary

{"This test detects 4-hydroxy xylazine in urine, a breakdown product of xylazine","It is a confirmatory test, meaning it verifies results from initial screening","Xylazine is primarily a veterinary sedative sometimes found in illicit drugs","The test helps healthcare providers confirm xylazine exposure in patients","Results are reported as either detected or not detected"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
103638-3
Short code
4-OH-XYL-UR
Synonyms
4OH-Xylazine Ur Cfm-mCnc
Category
chemistry
Sample
urine
Container
Clean, dry plastic urine container (60-120 mL capacity)
Units
N/A
Ref high
5
Fasting
false
Population
adult
Sex
all
Age range
≥ 13 years
Method
confirm
CPT
80307
SNOMED
122465009
Specimen volume
Minimum 10 mL, preferred 20-30 mL
Stability
Room temperature: 7 days; Refrigerated (2-8°C): 30 days; Frozen (-20°C or below): 90 days
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
48–96 hours
Order
routine

This test checks for the presence of xylazine in your body. Xylazine is a powerful sedative that is sometimes added to street drugs like heroin or fentanyl. The test is typically performed on a urine or blood sample and helps healthcare providers identify if you have been exposed to this substance, which can cause dangerous side effects such as slowed breathing, low blood pressure, and deep sedation that may last for hours.

This test looks for 4-hydroxy xylazine in your urine. 4-hydroxy xylazine is a substance produced when your body breaks down xylazine, a drug that acts as a sedative and pain reliever. This is a confirmatory test, which means it is used to confirm (verify) the results of an initial screening test.

Xylazine is a non-opioid tranquilizer originally developed for veterinary use to sedate and anesthetize large animals like horses and cattle. It is not approved for human use, but illicit drug dealers often mix it with opioids to increase their effects or stretch their supply. When consumed by humans, xylazine can cause drowsiness, confusion, and even coma, and its effects are not reversed by naloxone, the standard overdose reversal medication.

Xylazine is a medication primarily used in veterinary medicine to sedate animals, particularly large animals like horses and cattle. It is not approved for use in humans. However, xylazine has been found as an adulterant (additive) in some illicit street drugs, sometimes without the user's knowledge. When someone uses drugs contaminated with xylazine, their body processes it and produces 4-hydroxy xylazine, which can be detected in urine.

Your doctor might order this test if you show symptoms of a drug overdose that are not typical for opioids alone, such as prolonged sedation, a very slow heart rate, or skin wounds that appear quickly and are hard to heal. You may also need this test if you are in a substance use treatment program and your provider wants to monitor for possible xylazine exposure, or if you have been exposed to drugs contaminated with xylazine and need medical care for withdrawal or other complications.

Your healthcare provider may order this test if: (1) a preliminary urine drug screen was positive and confirmation is needed, (2) you have symptoms suggesting exposure to xylazine or contaminated substances, or (3) monitoring is required for other clinical reasons. This confirmatory test provides more specific and accurate information than initial screening tests.

The test is performed by collecting a small sample of your urine or blood. For a urine sample, you will be given a sterile cup and asked to provide a midstream sample in a private bathroom. For a blood test, a healthcare professional will draw blood from a vein in your arm using a needle. The sample is then sent to a laboratory where it is analyzed using advanced techniques like liquid chromatography and mass spectrometry. Results typically take a few days and are reviewed by your doctor, who will explain what they mean for your care.

A urine sample is collected, typically in a clean container provided by the laboratory. The sample is then sent to a lab where specialized equipment is used to detect and measure 4-hydroxy xylazine. The confirmatory method used is more specific than standard screening tests and can accurately identify whether xylazine exposure has occurred.

Reference range

Not Detected - Cutoff: 5 ng/mL (confirmatory threshold)N/A

Specimen: urine

Collect clean-catch midstream urine specimen. Avoid genital contact with container. Inform laboratory of any medications or supplements. No fasting required.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Detecting 4-hydroxy xylazine in urine confirms exposure to xylazine, which can cause sedation, dizziness, low blood pressure, and slowed heart rate. In humans, xylazine exposure—particularly from contaminated illicit drugs—may lead to adverse effects requiring medical intervention. Confirmatory testing is important because some initial screening tests may have false positives, and accurate identification of xylazine exposure guides appropriate clinical management and treatment.

This test may also be used in forensic or addiction medicine settings to monitor exposure patterns or in clinical trials studying xylazine metabolism. The detection window in urine is generally longer than in blood, making urine testing useful for confirming recent exposure.

Frequently asked questions

How long does xylazine stay in my system?
4-hydroxy xylazine can typically be detected in urine for several days after exposure, depending on factors such as the amount used, individual metabolism, and kidney function. The exact detection window varies from person to person.
Will this test show if I used other drugs?
No. This specific test only looks for 4-hydroxy xylazine (a metabolite of xylazine). It does not detect other drugs or substances. If your healthcare provider wants to check for other substances, they will order separate tests.
Do I need to prepare for this test?
No special preparation is typically needed. You should inform your healthcare provider about any medications or supplements you are taking, as some substances may potentially interfere with test results. Follow any specific instructions provided by your healthcare provider or the testing facility.
What do the results mean?
A "Detected" result means 4-hydroxy xylazine was found in your urine, indicating recent exposure to xylazine. A "Not Detected" result means no 4-hydroxy xylazine was found at the time of testing. Your healthcare provider will interpret these results in the context of your symptoms, medical history, and other test findings.
Is this test confidential?
Like all medical tests, your results are protected by healthcare privacy laws and are part of your confidential medical record. Test results are shared only with you and your authorized healthcare providers for medical purposes.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy